Article Listing - AstraZeneca and Bristol-Myers get first approval for diabetes drug Forxiga

CIBA-GEIGY SEEKS FOREIGN INVESTORS

11 May 1992

Swiss drugs major Ciba-Geigy will make strenuous efforts to gain more foreign investors as shareholders, according to supervisory council president,...

FISONS DIVESTS TO FOCUS ON PHARMACEUTICALS

11 May 1992

UK pharmaceutical, horticultural and scientific instruments concern, Fisons, has announced that it is to sell off its horticultural and consumer...

SYNTHELABO ACQUIRES VITA FARMACEUTICA

11 May 1992

French pharmaceutical concern Synthelabo has acquired, through its subsidiary LIRCA, the Italian company Vita Farmaceutici, which has products under license...

ICI AUSTRALIA CEASES EPHEDRIN PRODUCTION

11 May 1992

ICI Australia is to cease production at its ephedrine plant. The company has said that it will try to incorporate...

HOECHST AG - UTZ-HELLMUTH FELCHT

11 May 1992

Utz-Hellmuth Felcht is named to the board of Hoechst AG, with responsibility for research, following the retirement of Heinz Harnisch.

NOSE DROP FLU VACCINE

11 May 1992

A nose drop formulation of flu vaccine has proved safe and effective in infants aged 2-5 months, according to Phase...

GENENTECH'S EXPANDING PRODUCT PORTFOLIO

11 May 1992

Biotechnology major Genentech is planning to increase its research and development spending in 1992 to 50% of revenues, up from...

WHO WILL SUCCEED MERCK & CO CHIEF?

11 May 1992

US-based Merck & Co has a long-standing rule that executives must retire at the age of 65. And Roy Vagelos,...

CYMEVENE AND HEART TRANSPLANTS

11 May 1992

Administration of Syntex' Cymevene (ganciclovir) as a prophylactic to patients after they have received a heart transplant has been found...

BB & SB TO DEVELOP NEW MMPI PRODUCTS

11 May 1992

British Bio-technology Group and SmithKline Beecham have agreed to conduct collaborative research and commercialization of a class of compounds which...

Showing 94011-94020 of 95376 articles